Guardion Health Sciences, Inc. (GHSI)

USD 3.22

(0.0%)

Total Liabilities Summary of Guardion Health Sciences, Inc.

Guardion Health Sciences, Inc.'s latest annual total liabilities in 2023 was 3.77 Million USD , down -55.72% from previous year.
Guardion Health Sciences, Inc.'s latest quarterly total liabilities in 2024 Q1 was 6.99 Million USD , up 85.38% from previous quarter.
Guardion Health Sciences, Inc. reported annual total liabilities of 8.51 Million USD in 2022, up 632.52% from previous year.
Guardion Health Sciences, Inc. reported annual total liabilities of 1.16 Million USD in 2021, down -13.58% from previous year.
Guardion Health Sciences, Inc. reported quarterly total liabilities of 1.54 Million USD for 2024 Q2, down -77.85% from previous quarter.
Guardion Health Sciences, Inc. reported quarterly total liabilities of 3.77 Million USD for 2023 Q4, down -27.12% from previous quarter.

Annual Total Liabilities Chart of Guardion Health Sciences, Inc. (2023 - 2013)

Historical Annual Total Liabilities of Guardion Health Sciences, Inc. (2023 - 2013)

Year	Total Liabilities	Total Liabilities Growth
2023	3.77 Million USD	-55.72%
2022	8.51 Million USD	632.52%
2021	1.16 Million USD	-13.58%
2020	1.34 Million USD	59.25%
2019	844.98 Thousand USD	70.59%
2018	495.33 Thousand USD	-0.92%
2017	499.94 Thousand USD	-17.72%
2016	607.61 Thousand USD	-58.76%
2015	1.47 Million USD	-29.39%
2014	2.08 Million USD	52.88%
2013	1.36 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	6.99 Million USD	85.38%
2024 Q2	1.54 Million USD	-77.85%
2023 Q4	3.77 Million USD	-27.12%
2023 Q2	6.23 Million USD	4.98%
2023 FY	3.77 Million USD	-55.72%
2023 Q3	5.17 Million USD	-16.96%
2023 Q1	5.93 Million USD	-30.3%
2022 Q2	1.69 Million USD	-7.29%
2022 Q1	1.82 Million USD	57.06%
2022 FY	8.51 Million USD	632.52%
2022 Q4	8.51 Million USD	391.46%
2022 Q3	1.73 Million USD	2.36%
2021 Q2	1.99 Million USD	64.29%
2021 Q3	1.97 Million USD	-1.07%
2021 Q4	1.16 Million USD	-40.98%
2021 Q1	1.21 Million USD	-9.92%
2021 FY	1.16 Million USD	-13.58%
2020 Q2	1.33 Million USD	-13.3%
2020 Q3	1.47 Million USD	9.92%
2020 Q4	1.34 Million USD	-8.53%
2020 Q1	1.54 Million USD	82.68%
2020 FY	1.34 Million USD	59.25%
2019 Q3	906.21 Thousand USD	-10.28%
2019 FY	844.98 Thousand USD	70.59%
2019 Q4	844.98 Thousand USD	-6.76%
2019 Q2	1.01 Million USD	-51.5%
2019 Q1	2.08 Million USD	320.48%
2018 Q3	398.57 Thousand USD	-32.05%
2018 Q4	495.33 Thousand USD	24.28%
2018 FY	495.33 Thousand USD	-0.92%
2018 Q1	600 Thousand USD	20.01%
2018 Q2	586.52 Thousand USD	-2.25%
2017 Q2	769.01 Thousand USD	-3.54%
2017 Q1	797.26 Thousand USD	31.21%
2017 FY	499.94 Thousand USD	-17.72%
2017 Q4	499.94 Thousand USD	-33.91%
2017 Q3	756.49 Thousand USD	-1.63%
2016 Q1	- USD	-100.0%
2016 FY	607.61 Thousand USD	-58.76%
2016 Q4	607.61 Thousand USD	-70.9%
2016 Q3	2.08 Million USD	5.22%
2016 Q2	1.98 Million USD	0.0%
2015 Q1	- USD	-100.0%
2015 Q4	1.47 Million USD	33.5%
2015 Q3	1.1 Million USD	0.0%
2015 FY	1.47 Million USD	-29.39%
2014 FY	2.08 Million USD	52.88%
2014 Q4	2.08 Million USD	0.0%
2013 FY	1.36 Million USD	0.0%

Peer Total Liabilities Comparison of Guardion Health Sciences, Inc.

Name	Total Liabilities	Total Liabilities Difference
Bright Green Corporation	6.43 Million USD	41.409%
BioQuest Corp.	632.89 Thousand USD	-496.012%
Clever Leaves Holdings Inc.	7.02 Million USD	46.312%
Eagle Pharmaceuticals, Inc.	172.6 Million USD	97.815%
GSRX Industries Inc.	- USD	-Infinity%
High Sierra Technologies, Inc.	611.78 Thousand USD	-516.578%
Instadose Pharma Corp.	- USD	-Infinity%